COMMUNIQUÉS West-GlobeNewswire

TESARO, Inc. Gives Notice of Anticipated Make-Whole Adjustment Event to Holders of Its Convertible Senior Notes
04/12/2018
WALTHAM, Mass., Dec. 04, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that, pursuant to the terms of the indenture (the “Indenture”) governing the [...]
Sol-Gel Technologies Announces Sixth Agreement for a Generic Product Candidate with Perrigo
04/12/2018
NESS ZIONA, Israel, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (NASDAQ: SLGL) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing [...]
IRIDEX Announces Departure of Chief Financial Officer and Reiterates Full Year 2018 Guidance
04/12/2018
MOUNTAIN VIEW, Calif., Dec. 04, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced Chief Financial Officer Atabak Mokari will leave the Company for a senior finance executive role at another [...]
Novavax Announces Leadership Promotions
04/12/2018
GAITHERSBURG, Md., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX) today announced the promotion of Jill Hoyt to Senior Vice President of Human Resources and Biegie Lee to Vice President of Information [...]
GBT Announces New Employment Inducement Grants
04/12/2018
SOUTH SAN FRANCISCO, Calif., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT or the Company) (NASDAQ: GBT) today announced that, on November 30, 2018, the compensation committee of the Company’s [...]
HealthEquity Reports Third Quarter Ended October 31, 2018 Financial Results
04/12/2018
Highlights of the third quarter include: Revenue of $70.5 million, an increase of 24% compared to Q3 FY18. Net income of $15.7 million, an increase of 50% compared to Q3 FY18. Net income per diluted share of $0.25 [...]
RedHill Biopharma Announces Proposed Public Offering of its American Depositary Shares
04/12/2018
TEL-AVIV, Israel and RALEIGH, N.C., Dec. 04, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]
MediPharm Labs Wins Canadian Cannabis Start-Up of the Year
04/12/2018
Award endorses MediPharm Labs Business Model TORONTO, Dec. 04, 2018 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (the “ Company ” or “ MediPharm Labs ”) has been named the Cannabis Start-up of the Year at the [...]
Stryker increases dividend 11%, declaring a $0.52 per share quarterly dividend
04/12/2018
Kalamazoo, Michigan, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Kalamazoo, Michigan – December 4, 2018 – Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.52 per share [...]
Tetra Bio-Pharma Responds to Shareholders
04/12/2018
“Tetra is Not a Cannabis Company” Says CEO Chamberland ORLEANS, Ontario, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc (“ Tetra ” or “ TBP ”), (TSX VENTURE: TBP) (OTCQB: TBPMF) - Recent news regarding Aphria [...]
Data for BeyondSpring’s Lead Asset, Plinabulin, for Chemotherapy-Induced Neutropenia (CIN) Prevention Shows Differentiated Profile Compared with G-CSF and Adds Additional Protection to G-CSF
04/12/2018
BeyondSpring Presented Latest Clinical Results at 2018 American Society of Hematology (ASH) Annual Meeting Plinabulin monotherapy is an equally effective single-dose-per cycle agent as pegfilgrastim, but with minimal [...]
Holding(s) in Company
04/12/2018
Holding(s) in Company December 4, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG) 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii : Shire plc (LEI: [...]
Allscripts to present at the Citi 2018 Global Healthcare Conference
04/12/2018
CHICAGO, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX) today announced that certain members of its management team will present at the Citi 2018 Global Healthcare Conference in New York, NY on Thursday, [...]
Agility Health Subsidiaries File Notice of Intention to Make a Proposal Under the Bankruptcy and Insolvency Act (Canada)
04/12/2018
HAMILTON, Ontario, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Agility Health, Inc. (TSXV: AHI) (“ Agility Health ” or “ Company ”) announces that on December 3, 2018, four of the Company’s operating subsidiaries; Ontario [...]
VALNEVA to Conduct Investor and Partnering Meetings During the 37th Annual J.P. Morgan Healthcare Conference
04/12/2018
Valneva to Conduct Investor and Partnering Meetings During the 37 th Annual J.P. Morgan Healthcare Conference Saint-Herblain (France), December 4, 2018 - Valneva SE ("Valneva"), a biotech company developing and [...]
VALNEVA rencontrera investisseurs et partenaires potentiels lors de la J.P. Morgan Healthcare Conference
04/12/2018
Valneva rencontrera investisseurs et partenaires potentiels lors de la J.P. Morgan Healthcare Conference Saint-Herblain (France), 4 décembre 2018 - Valneva SE ("Valneva"), société de biotechnologie développant et [...]
Innovate Biopharmaceuticals Enters into a Collaboration with Massachusetts General Hospital and Announces Capital Update for the Celiac Disease Clinical Program and its NASH Development Strategy on December 17, 2018
04/12/2018
-- Announces collaboration in high unmet need Alcoholic Liver Diseases (ALD), including severe alcoholic hepatitis, with novel gut-specific, clinical-stage asset, larazotide acetate -- Investor update on capital plan [...]
CAPS® Expands National Footprint, Opens New 503B Compounding Outsourcing Facility in Phoenix
04/12/2018
New facility brings nearly 400 jobs and the latest engineering and technology in sterile compounding to the western U.S. IRVINE, Calif., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Central Admixture Pharmacy Services, Inc. (CAPS [...]
Claus Frisenberg Pedersen, CCO in Oncology Venture buys shares in the Company
04/12/2018
Company Announcement Claus Frisenberg Pedersen, CCO in Oncology Venture buys shares in the Company Hoersholm, Denmark – December 4, 2018 – Oncology Venture A/S (OV:ST) announces that CCO Claus Frisenberg Pedersen has [...]

Pages